GlassScriptPhysician profile
Amber Ellyn Holbein
NPI 1184247900
$430.25
in general payments reported to CMS, 2019-2025
9 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.91 · 2024: $88.12 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $97.00 | 2024-2025 | Zepbound, Mounjaro |
| Sumitomo Pharma America, INC. | $83.42 | 2025 | Gemtesa |
| Novo Nordisk INC | $70.06 | 2025 | Saxenda, Wegovy |
| Astrazeneca Pharmaceuticals LP | $65.13 | 2024-2025 | Breztri, Farxiga |
| Stryker Corporation | $49.16 | 2025 | Ortholoc 3di, Actishield, Dart-Fire |
| Bioventus LLC | $20.67 | 2025 | Exogen Ultrasound Bone Healing System |
| Dexcom, INC. | $16.91 | 2022 | |
| Sage Therapeutics, LLC | $14.56 | 2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $13.34 | 2024 | Capvaxive, Gardasil, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Holbein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.